PLRX
Price
$3.08
Change
+$0.07 (+2.33%)
Updated
Feb 21 closing price
Capitalization
187.43M
9 days until earnings call
SLDB
Price
$5.78
Change
-$0.22 (-3.67%)
Updated
Feb 21 closing price
Capitalization
441.12M
Ad is loading...

PLRX vs SLDB

Header iconPLRX vs SLDB Comparison
Open Charts PLRX vs SLDBBanner chart's image
Pliant Therapeutics
Price$3.08
Change+$0.07 (+2.33%)
Volume$2.09M
Capitalization187.43M
Solid Biosciences
Price$5.78
Change-$0.22 (-3.67%)
Volume$2.19M
Capitalization441.12M
PLRX vs SLDB Comparison Chart
Loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PLRX vs. SLDB commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PLRX is a Hold and SLDB is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (PLRX: $3.08 vs. SLDB: $5.78)
Brand notoriety: PLRX and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PLRX: 109% vs. SLDB: 78%
Market capitalization -- PLRX: $187.43M vs. SLDB: $441.12M
PLRX [@Biotechnology] is valued at $187.43M. SLDB’s [@Biotechnology] market capitalization is $441.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PLRX’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 1 green FA rating(s).

  • PLRX’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 1 green, 4 red.
According to our system of comparison, SLDB is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PLRX’s TA Score shows that 4 TA indicator(s) are bullish while SLDB’s TA Score has 5 bullish TA indicator(s).

  • PLRX’s TA Score: 4 bullish, 5 bearish.
  • SLDB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SLDB is a better buy in the short-term than PLRX.

Price Growth

PLRX (@Biotechnology) experienced а +1.32% price change this week, while SLDB (@Biotechnology) price change was +43.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

PLRX is expected to report earnings on May 12, 2025.

SLDB is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($441M) has a higher market cap than PLRX($187M). SLDB YTD gains are higher at: 44.500 vs. PLRX (-76.614). SLDB has higher annual earnings (EBITDA): -108.63M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. SLDB (171M). SLDB has less debt than PLRX: SLDB (24.7M) vs PLRX (60.2M). PLRX (0) and SLDB (0) have equivalent revenues.
PLRXSLDBPLRX / SLDB
Capitalization187M441M42%
EBITDA-197.04M-108.63M181%
Gain YTD-76.61444.500-172%
P/E RatioN/AN/A-
Revenue00-
Total Cash405M171M237%
Total Debt60.2M24.7M244%
FUNDAMENTALS RATINGS
SLDB: Fundamental Ratings
SLDB
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PLRXSLDB
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCEIX10.81-0.06
-0.55%
Virtus Westchester Event-Driven Fd I
PETGX14.02-0.19
-1.34%
Gabelli Pet Parents'™ A
SMYIX25.07-0.41
-1.61%
Franklin Global Equity I
KAUFX5.53-0.16
-2.81%
Federated Hermes Kaufmann R
JACLX18.17-0.70
-3.71%
JHancock Mid Cap Growth C

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with ALLO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-3.67%
ALLO - SLDB
41%
Loosely correlated
-3.77%
INZY - SLDB
41%
Loosely correlated
-1.57%
MGTX - SLDB
41%
Loosely correlated
+6.88%
PLRX - SLDB
40%
Loosely correlated
+2.33%
DNTH - SLDB
39%
Loosely correlated
-0.13%
More